Genome Medicine is calling for submission to a new Collection on translating the microbiome in health and disease.
Over the past two decades progress in the study of the human microbiome has accelerated. Critical to this advancement is the advent of novel technologies which have allowed the interrogation of the complex host-microbiome relationship. These tools, techniques and methods have helped accomplish the phylogenomic characterization of diverse microbiomes, permitted the functional profiling of microbiome data, and have given us a deeper understanding of how the microbiome relates to different disease states and mechanisms. Particularly intriguing is how the analysis of microbiome and multi-omics data can be utilized for clinical benefit and improve patient care.
To capture advances in this growing area, Genome Medicine is pleased to announce a call for papers for our upcoming special collection on ‘Translating the microbiome in health and disease,’ guest edited by Peggy Lai from Harvard University We are particularly interested in encouraging collaboration between basic and clinical researchers. The Guest Editor may be able to provide guidance on fostering such collaborations; please contact the editorial team to discuss further.
We are now inviting the submission of Research, Method, Software, Database and Guideline manuscripts of outstanding interest describing insights into all aspects of the human microbiome in health and disease including:
- Metagenomics and integrative multi-omics
- Microbiome analysis tools and technologies
- Artificial intelligence approaches
- Single-cell tools and technologies
- Long-read sequencing
- Healthy microbiome
- The aging microbiome
- The maternal microbiome
- The fetal, preterm and infant microbiome
- Trans-ethnic microbiome diversity
- Metabolic disorders and the role of diet
- Microbiome-immune homeostasis and regulation of the immune response
- Host-microbiome interactions
- Microbiome-encoded disease phenotypes
- The cancer and tumor microbiome
- Microbiome in tumor immunity and therapeutic response
- Translational interventions, clinical trials and therapies
- Infectious disease microbiome
- Gut-brain axis
- The human virome
- The human mycobiome
- In vivo microbiome construction
- Microbiome diagnostics
- FMT dynamics and efficacy
- Precision editing/modulation of the microbiome
- Translational interventions, clinical trials and therapies
Image credit: Viks_jin / Stock.adobe.com